Bionovate Technologies Corp
Bionovate Technologies Corp (BIIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
BIIO · revenue · updated Jun 13, 2026
Core revenue metrics
Trailing 12 monthsBionovate Technologies Corp trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2021.
Revenue trend
2021 – 2011 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-06-30 | $0.00B | +$0.00B | — |
| 2020-06-30 | $0.00B | +$0.00B | — |
| 2019-06-30 | $0.00B | +$0.00B | — |
| 2018-06-30 | $0.00B | -$0.00B | -100.00% |
| 2017-06-30 | $0.00B | -$0.00B | -11.96% |
| 2016-06-30 | $0.00B | +$0.00B | +37.95% |
| 2015-06-30 | $0.00B | -$0.00B | -46.24% |
| 2014-06-30 | $0.00B | -$0.00B | -71.40% |
| 2013-06-30 | $0.00B | -$0.00B | -17.13% |
| 2012-06-30 | $0.00B | +$0.00B | +51.66% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bionovate Technologies Corp receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bionovate Technologies Corp reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bionovate Technologies Corp's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BIIO revenue · 4 questionsBIIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2021.
▸ Source: FMP · Bionovate Technologies Corp SEC filings · GAAP · Bionovate Technologies Corp SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 13, 2026